STAAR Surgical Financial Activities - Other 2010-2025 | STAA

STAAR Surgical financial activities - other from 2010 to 2025. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
STAAR Surgical Annual Financial Activities - Other
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $0
2017 $N/A
2016 $N/A
2015 $0
2014 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
2010 $0
2009 $0
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.930B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.910B 21.47
Becton Dickinson (BDX) United States $49.385B 12.23
Cardinal Health (CAH) United States $36.396B 19.06
Straumann Holding AG (SAUHY) Switzerland $20.753B 0.00
Labcorp (LH) United States $20.246B 16.42
Cooper (COO) United States $15.859B 21.03
West Pharmaceutical Services (WST) United States $14.979B 31.40
Align Technology (ALGN) United States $12.512B 24.84
Henry Schein (HSIC) United States $8.682B 14.89
Merit Medical Systems (MMSI) United States $5.621B 27.17
DENTSPLY SIRONA (XRAY) United States $3.159B 9.43
CONMED (CNMD) United States $1.734B 12.98
Lifevantage (LFVN) United States $0.166B 17.14
Pro-Dex (PDEX) United States $0.149B 16.29